社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
天星医疗(01609)
201.000
-15.400
-7.12%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
二狗叨叨
·
05-07
【港股打新】英派药业-B 申购策略
图片一、基本信息
$英派药业-B(07630)$
，成立于2009年，是一家处于商业化阶段的生物技术公司，致力于在全球范围内推进基于合成致死机制的精准抗癌疗法，打造创新疗法，以满足癌症患者未被满足的医疗需求。。。公司通过自主研发建立了最全面、最先进的合成致死产品组合之一，也是全球仅有的三家同时拥有商业化阶段的PARP1/2抑制剂和临床阶段新一代PARP1选择性抑制剂的公司之一。。。公司已搭建双载荷抗体偶联药物（ADC）平台及蛋白降解剂平台，研发管线覆盖PARP1/2、PARP1、ATR、WEE1、PKMYT1/WEE1、DHX9、ATM、USP1及CHK1/2等关键合成致死靶点的小分子抑制剂，以及CEACAM5双载荷抗体偶联药物和KAT6A选择性蛋白降解剂。。。核心产品塞纳帕利（IMP4297）于2025年1月获批用于中国卵巢癌 “全人群” 一线维持治疗后正式启动商业化，并自2026年1月1日起纳入国家医保药品目录。塞纳帕利在中国卵巢癌 “全人群” 一线维持治疗的 PARP1/2 抑制剂中（非头对头研究）中实现了最有利的PFS结果，为该类药物树立了新标杆。。。。二、招股信息公司名称及代码：英派药业-B（07666.HK）招股价：10.50KD入场费：5302.95HKD（1手500股）招股日期：05月05至05月08日，本周五截止公布中签：05月11日上市：05月13日发售股份：2.02亿股，占总股本17.46%分配机制：机制B市值：121.01亿HKD绿鞋：有。。。基石：8名基石共认购占比32.15%，阵容还算不错保荐人：高盛、中金！三、基本面情况公司在2022年、2023年和2024年，实现营收分别约为2.35亿元、0.34亿元、0.38亿，期间公司净利润分别为-0.20亿元、-2.55亿元
【港股打新】英派药业-B 申购策略
精彩
稻草人的风筝:
什么意思，三个账户，两个全额融资，一个现金摸，全打英派，不打剂泰科技吗？
回复
2
点赞
4
编组 21备份 2
分享
举报
云在水里
·
05-04
$天星医疗(01609)$
450以内随便接，明天能上500
$天星医疗(01609)$ 450以内随便接，明天能上500
精彩
张勇敢:
只剩500一半喽
回复
6
点赞
6
编组 21备份 2
分享
举报
domibest
·
05-04
$天星医疗(01609)$
哪一个是卖在601的幸运选手啊！[财迷]
$天星医疗(01609)$ 哪一个是卖在601的幸运选手啊！[财迷]
精彩
All In 9:
应该没人吧，卖不出去
回复
4
点赞
2
编组 21备份 2
分享
举报
上帝不离不弃
·
05-04
$天星医疗(01609)$
明天还上500吗？
$天星医疗(01609)$ 明天还上500吗？
回复
2
点赞
2
编组 21备份 2
分享
举报
Seek放牛娃
·
05-05
$乐动机器人(01236)$
打新太疯狂了
$天星医疗(01609)$
抽中就是赚哟，让我中一签
$乐动机器人(01236)$ 打新太疯狂了$天星医疗(01609)$ 抽中就是赚哟，让我中一签
回复
评论
点赞
2
编组 21备份 2
分享
举报
Bestcsx
·
05-04
$天星医疗(01609)$
感谢
$天星医疗(01609)$ 感谢
回复
评论
点赞
7
编组 21备份 2
分享
举报
曹 煜
·
05-04
$天星医疗(01609)$
$天星医疗(01609)$
回复
1
点赞
3
编组 21备份 2
分享
举报
Tigerwood1234
·
05-05
$天星医疗(01609)$
先食肉
$天星医疗(01609)$ 先食肉
回复
评论
点赞
1
编组 21备份 2
分享
举报
二狗叨叨
·
05-04
【港股打新】乐动机器人 申购策略
五一小长假继续，大A股不开盘，港股打了鸡血，恒指和恒科都暴涨，尤其是下午
$天星医疗(01609)$
暗盘，暴涨200+%，一手至少赚1w，真的是大超预期。。。 只可惜，二狗哥没中，没吃到肉。。。。 一、基本信息
$乐动机器人(01236)$
，成立于 2017 年，是全球领先的全栈式智能机器人视觉感知企业，聚焦机器人 “传感器+算法+云平台” 核心技术，成为“智能机器人移动感知第一股”。。。 公司构建To B视觉感知解决方案与To C智能割草机器人双轮驱动格局，自研DTOF激光雷达2024年出货量全球第一，技术赋能超600万台智能机器人，服务全球 300余家头部客户，业务覆盖50余个国家和地区。。。 二、招股信息 公司名称及代码：乐动机器人（01236.HK） 招股价：24.00-30.00KD 入场费：6060.51HKD（1手200股） 招股日期：04月30至05月06日，本周三截止 公布中签：05月07日 上市：05月11日 发售股份：3333.34w股，占总股本10% 分配机制：机制B 市值：80-100亿HKD 绿鞋：有。。。 基石：1名基石共认购占比30.78%。。。 保荐人：海通、国泰 三、基本面情况 公司在2022年、2023年和2024年，实现营收分别约为2.77亿元、4.67亿元、7.48亿，复合年增长率64%，期间公司净利润分别为-0.68亿元、-0.56亿元、-0.63亿元，复合年增长率21.3%。。。 四、申购策略 1、公司基本面一般情况，发展很快，不过还未盈利。。。。 2、概念不错，能炒一波。。。 3、公司按照机制B发行，甲乙组共计16666手，货不多，今天下午天星的资金也回来了，估
【港股打新】乐动机器人 申购策略
精彩
采桑散人:
二狗哥，你用的什么APP？@二狗叨叨
回复
3
点赞
4
编组 21备份 2
分享
举报
Frankie Kan
·
05-04
$天星医疗(01609)$
我猜明天开市升少下午跌
$天星医疗(01609)$ 我猜明天开市升少下午跌
回复
评论
点赞
2
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
天星医疗
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.starsportmed.com/
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
北京天星医疗股份有限公司(简称“天星医疗”)作为国产运动医学的领导者,致力于提供运动医学的整体临床解决方案,公司坐落于北京经济技术开发区,注册资本4000多万,现有员工200余人。应用于肩关节、膝关节、足/踝关节、髋关节、肘关节、手/腕关节的运动医学设备、植入物和手术器械共计300多个品规通过NMPA的批准,临床应用于国内31个省市、自治区的数千家医院。主要从事运动医学植入物、有源设备及耗材,以及手术工具的研发、生产与销售。
04-24
股份发售
全球发售
全球发售
2023-12-15
半年度报告
中期报告2023
中期报告2023
2023-11-23
半年度报告
截至二零二三年九月三十日止六个月的中期业绩公告
截至二零二三年九月三十日止六个月的中期业绩公告
2023-11-21
须予披露的交易
(1)有关收购广州市祥景陵园有限公司59%股权之非常重大收购事项及关连交易；(2)涉及新上市申请之反收购；及(3)有关贷款转让之须予披露及关连交易
(1)有关收购广州市祥景陵园有限公司59%股权之非常重大收购事项及关连交易；(2)涉及新上市申请之反收购；及(3)有关贷款转让之须予披露及关连交易
2023-09-29
收购
(1)红日资本有限公司代表创建集团（控股）有限公司提出回购最多120,000,000股股份作注销并交换经调整国耀股份的有条件股份回购结束；(2)回购要约结束；及(3)回购要约结算
(1)红日资本有限公司代表创建集团（控股）有限公司提出回购最多120,000,000股股份作注销并交换经调整国耀股份的有条件股份回购结束；(2)回购要约结束；及(3)回购要约结算
2023-09-15
收购
(1)于二零二三年九月十五日举行的股东特别大会投票表决结果(2)回购要约在所有方面成为无条件及(3)回购要约仍可供接纳
(1)于二零二三年九月十五日举行的股东特别大会投票表决结果(2)回购要约在所有方面成为无条件及(3)回购要约仍可供接纳
2023-08-24
收购
延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件
延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件
2023-08-24
收购
创建集团（控股）有限公司已发行股本中每股面值0.01港元普通股之接纳及转让表格
创建集团（控股）有限公司已发行股本中每股面值0.01港元普通股之接纳及转让表格
2023-08-24
收购
要约文件(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易及股东特别大会通告
要约文件(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易及股东特别大会通告
2023-08-18
收购
进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份；及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件
进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份；及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件
2023-07-21
收购
进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件
进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件
2023-07-12
年度报告
2023 年报
2023 年报
2023-07-12
股份购回
建议更新发行新股份及回购股份的一般授权、扩大发行授权、重选退任董事、续聘独立核数师、建议修订组织章程大纲及细则及采纳经修订及重述组织章程大纲及细则及股东周年大会通告
建议更新发行新股份及回购股份的一般授权、扩大发行授权、重选退任董事、续聘独立核数师、建议修订组织章程大纲及细则及采纳经修订及重述组织章程大纲及细则及股东周年大会通告
2023-06-26
收购
进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件
进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件
2023-06-12
年度报告
截至二零二三年三月三十一日止年度之全年业绩公告
截至二零二三年三月三十一日止年度之全年业绩公告
分时
5日
日
周
月
数据加载中...
最高
218.200
今开
216.400
量比
0.16
最低
199.200
昨收
216.400
换手率
0.39%
热议股票
{"pagemeta":{"title":"天星医疗(01609)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供天星医疗(01609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"天星医疗,01609,天星医疗股票,天星医疗股票老虎,天星医疗股票老虎国际,天星医疗行情,天星医疗股票行情,天星医疗股价,天星医疗股市,天星医疗股票价格,天星医疗股票交易,天星医疗股票购买,天星医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"天星医疗(01609)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供天星医疗(01609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"01609","data":{"stockData":{"symbol":"01609","market":"HK","secType":"STK","nameCN":"天星医疗","latestPrice":201,"timestamp":1778227681518,"preClose":216.4,"halted":0,"volume":213150,"delay":0,"changeRate":-0.07116451016635862,"floatShares":54831344,"shares":54831344,"eps":0.021242,"marketStatus":"休市中","change":-15.4,"latestTime":"05-08 16:08:01","open":216.4,"high":218.2,"low":199.2,"amount":43895960,"amplitude":0.0878,"askPrice":201.2,"askSize":400,"bidPrice":201,"bidSize":1700,"shortable":0,"etf":0,"ttmEps":2.766,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778463000000},"marketStatusCode":7,"adr":0,"listingDate":1777910400000,"exchange":"SEHK","adjPreClose":216.4,"openAndCloseTimeList":[[1778203800000,1778212800000],[1778216400000,1778227200000]],"volumeRatio":0.1632185175373265,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.561467493892448","cardData":[{"tweetId":"561467493892448","author":{"authorId":"3498690247998564","idStr":"3498690247998564","name":"二狗叨叨","avatar":"https://static.tigerbbs.com/55e1bdc35fbca55dc650568445c5703e","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":1,"crmLevelSwitch":1,"wearingBadges":[],"fanSize":1972,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"【港股打新】英派药业-B 申购策略","digest":"图片一、基本信息<a href=\"https://laohu8.com/S/07630\">$英派药业-B(07630)$</a> ，成立于2009年，是一家处于商业化阶段的生物技术公司，致力于在全球范围内推进基于合成致死机制的精准抗癌疗法，打造创新疗法，以满足癌症患者未被满足的医疗需求。。。公司通过自主研发建立了最全面、最先进的合成致死产品组合之一，也是全球仅有的三家同时拥有商业化阶段的PARP1/2抑制剂和临床阶段新一代PARP1选择性抑制剂的公司之一。。。公司已搭建双载荷抗体偶联药物（ADC）平台及蛋白降解剂平台，研发管线覆盖PARP1/2、PARP1、ATR、WEE1、PKMYT1/WEE1、DHX9、ATM、USP1及CHK1/2等关键合成致死靶点的小分子抑制剂，以及CEACAM5双载荷抗体偶联药物和KAT6A选择性蛋白降解剂。。。核心产品塞纳帕利（IMP4297）于2025年1月获批用于中国卵巢癌 “全人群” 一线维持治疗后正式启动商业化，并自2026年1月1日起纳入国家医保药品目录。塞纳帕利在中国卵巢癌 “全人群” 一线维持治疗的 PARP1/2 抑制剂中（非头对头研究）中实现了最有利的PFS结果，为该类药物树立了新标杆。。。。二、招股信息公司名称及代码：英派药业-B（07666.HK）招股价：10.50KD入场费：5302.95HKD（1手500股）招股日期：05月05至05月08日，本周五截止公布中签：05月11日上市：05月13日发售股份：2.02亿股，占总股本17.46%分配机制：机制B市值：121.01亿HKD绿鞋：有。。。基石：8名基石共认购占比32.15%，阵容还算不错保荐人：高盛、中金！三、基本面情况公司在2022年、2023年和2024年，实现营收分别约为2.35亿元、0.34亿元、0.38亿，期间公司净利润分别为-0.20亿元、-2.55亿元","plainDigest":"图片一、基本信息$英派药业-B(07630)$ ，成立于2009年，是一家处于商业化阶段的生物技术公司，致力于在全球范围内推进基于合成致死机制的精准抗癌疗法，打造创新疗法，以满足癌症患者未被满足的医疗需求。。。公司通过自主研发建立了最全面、最先进的合成致死产品组合之一，也是全球仅有的三家同时拥有商业化阶段的PARP1/2抑制剂和临床阶段新一代PARP1选择性抑制剂的公司之一。。。公司已搭建双载荷抗体偶联药物（ADC）平台及蛋白降解剂平台，研发管线覆盖PARP1/2、PARP1、ATR、WEE1、PKMYT1/WEE1、DHX9、ATM、USP1及CHK1/2等关键合成致死靶点的小分子抑制剂，以及CEACAM5双载荷抗体偶联药物和KAT6A选择性蛋白降解剂。。。核心产品塞纳帕利（IMP4297）于2025年1月获批用于中国卵巢癌 “全人群” 一线维持治疗后正式启动商业化，并自2026年1月1日起纳入国家医保药品目录。塞纳帕利在中国卵巢癌 “全人群” 一线维持治疗的 PARP1/2 抑制剂中（非头对头研究）中实现了最有利的PFS结果，为该类药物树立了新标杆。。。。二、招股信息公司名称及代码：英派药业-B（07666.HK）招股价：10.50KD入场费：5302.95HKD（1手500股）招股日期：05月05至05月08日，本周五截止公布中签：05月11日上市：05月13日发售股份：2.02亿股，占总股本17.46%分配机制：机制B市值：121.01亿HKD绿鞋：有。。。基石：8名基石共认购占比32.15%，阵容还算不错保荐人：高盛、中金！三、基本面情况公司在2022年、2023年和2024年，实现营收分别约为2.35亿元、0.34亿元、0.38亿，期间公司净利润分别为-0.20亿元、-2.55亿元","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1778108720139,"gmtModify":1778118968463,"symbols":["07666","01236","07630","01609"],"themeIds":["e4363384c4254650b897c0f13fe1588f"],"popularizeThemeFlag":false,"imageCount":2,"images":[{"url":"https://static.tigerbbs.com/f81e8aebd67a7870c009231a177f8c11"}],"repostCount":0,"viewCount":15863,"likeCount":4,"liked":false,"collected":false,"commentCount":2,"hotComments":[{"id":"561697017128144","author":{"authorId":"3548712052573855","idStr":"3548712052573855","name":"稻草人的风筝","avatar":"https://static.tigerbbs.com/bbe8c366cd157bd0ed68672768c0b052","userType":1,"introduction":"","crmLevel":3,"crmLevelSwitch":0,"fanSize":0,"starInvestorFlag":false},"content":"什么意思，三个账户，两个全额融资，一个现金摸，全打英派，不打剂泰科技吗？","plainContent":"什么意思，三个账户，两个全额融资，一个现金摸，全打英派，不打剂泰科技吗？","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/561467493892448","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":true,"length":1969,"displayRows":4,"foldSize":0,"authorId":"3498690247998564"}]},{"cardType":"TWEET","cardId":"TWEET.560542963037832","cardData":[{"tweetId":"560542963037832","author":{"authorId":"3480642554744164","idStr":"3480642554744164","name":"云在水里","avatar":"https://static.tigerbbs.com/151ae8c8981b236d60f95278bdf85e24","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"wearingBadges":[],"fanSize":7,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/01609\">$天星医疗(01609)$</a> 450以内随便接，明天能上500","plainDigest":"$天星医疗(01609)$ 450以内随便接，明天能上500","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1777883066950,"gmtModify":1777883068999,"symbols":["01609"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":2503,"likeCount":6,"liked":false,"collected":false,"commentCount":6,"hotComments":[{"id":"560790574466632","author":{"authorId":"3460936851420478","idStr":"3460936851420478","name":"张勇敢","avatar":"https://static.tigerbbs.com/4db3fa4ad0c505947a9d6fde62bc6b06","userType":1,"introduction":"","crmLevel":6,"crmLevelSwitch":0,"fanSize":10,"starInvestorFlag":false},"content":"只剩500一半喽","plainContent":"只剩500一半喽","likeCount":0,"commentType":"valid","coins":0},{"id":"560559011169144","author":{"authorId":"3479346464715704","idStr":"3479346464715704","name":"肉松爱老虎","avatar":"https://static.tigerbbs.com/d618fe7e35727746729bc9bdf031dccc","userType":1,"introduction":"","crmLevel":7,"crmLevelSwitch":0,"fanSize":40,"starInvestorFlag":false},"content":"那你砸锅卖铁去接没？","plainContent":"那你砸锅卖铁去接没？","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/560542963037832","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":42,"displayRows":4,"foldSize":0,"authorId":"3480642554744164"}]},{"cardType":"TWEET","cardId":"TWEET.560542369560544","cardData":[{"tweetId":"560542369560544","author":{"authorId":"4185760841922922","idStr":"4185760841922922","name":"domibest","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/6444b4970948c1077534c593eccd6d16","hat":"https://static.tigerbbs.com/6444b4970948c1077534c593eccd6d16","crmLevel":3,"crmLevelSwitch":0,"wearingBadges":[],"fanSize":16,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/01609\">$天星医疗(01609)$</a> 哪一个是卖在601的幸运选手啊！[财迷] ","plainDigest":"$天星医疗(01609)$ 哪一个是卖在601的幸运选手啊！[财迷]","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1777882943289,"gmtModify":1777882945321,"symbols":["01609"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":2378,"likeCount":2,"liked":false,"collected":false,"commentCount":4,"hotComments":[{"id":"560542896109456","author":{"authorId":"4199240178310972","idStr":"4199240178310972","name":"All In 9","avatar":"https://static.tigerbbs.com/4df1b3d4f743ad10c845b58e1666ae49","userType":1,"introduction":"","crmLevel":5,"crmLevelSwitch":1,"fanSize":1,"starInvestorFlag":false},"content":"应该没人吧，卖不出去","plainContent":"应该没人吧，卖不出去","likeCount":0,"commentType":"hot","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/560542369560544","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":51,"displayRows":4,"foldSize":0,"authorId":"4185760841922922"}]},{"cardType":"TWEET","cardId":"TWEET.560572664567408","cardData":[{"tweetId":"560572664567408","author":{"authorId":"4200638915699862","idStr":"4200638915699862","name":"上帝不离不弃","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":7,"crmLevelSwitch":1,"wearingBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","name":"实盘交易者","description":"完成一笔实盘交易","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","isScarce":0,"effectEnabled":0,"redirectLinkEnabled":0,"redirectLinkValidityFrom":0,"redirectLinkValidityTo":9223372036854776000}],"fanSize":24,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/01609\">$天星医疗(01609)$ </a> 明天还上500吗？","plainDigest":"$天星医疗(01609)$ 明天还上500吗？","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1777890285179,"gmtModify":1777890287041,"symbols":["01609"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1451,"likeCount":2,"liked":false,"collected":false,"commentCount":2,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/560572664567408","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":31,"displayRows":4,"foldSize":0,"authorId":"4200638915699862"}]},{"cardType":"TWEET","cardId":"TWEET.560828203995592","cardData":[{"tweetId":"560828203995592","author":{"authorId":"4240295506800712","idStr":"4240295506800712","name":"Seek放牛娃","avatar":"https://static.tigerbbs.com/82d453b016232f2384cc803522e3f547","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"wearingBadges":[],"fanSize":3,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/01236\">$乐动机器人(01236)$</a> 打新太疯狂了<a href=\"https://laohu8.com/S/01609\">$天星医疗(01609)$ </a> 抽中就是赚哟，让我中一签","plainDigest":"$乐动机器人(01236)$ 打新太疯狂了$天星医疗(01609)$ 抽中就是赚哟，让我中一签","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1777952644297,"gmtModify":1777955266455,"symbols":["01236","01609"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":453,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/560828203995592","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":71,"displayRows":4,"foldSize":0,"authorId":"4240295506800712"}]},{"cardType":"TWEET","cardId":"TWEET.560544596803856","cardData":[{"tweetId":"560544596803856","author":{"authorId":"3498518073987781","idStr":"3498518073987781","name":"Bestcsx","avatar":"https://static.tigerbbs.com/33124ecec8d4b28ad058296b4d1235dc","userType":1,"introduction":"","crmLevel":8,"crmLevelSwitch":0,"wearingBadges":[],"fanSize":1,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/01609\">$天星医疗(01609)$</a> 感谢","plainDigest":"$天星医疗(01609)$ 感谢","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1777883402650,"gmtModify":1777883414520,"symbols":["01609"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/8080c8b4d28c989e68dc5eded28dd223","width":"1290","height":"2796"}],"repostCount":0,"viewCount":681,"likeCount":7,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/560544596803856","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":21,"displayRows":4,"foldSize":0,"authorId":"3498518073987781"}]},{"cardType":"TWEET","cardId":"TWEET.560541864522912","cardData":[{"tweetId":"560541864522912","author":{"authorId":"4182048476464190","idStr":"4182048476464190","name":"曹 煜","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":5,"crmLevelSwitch":0,"wearingBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/01609\">$天星医疗(01609)$ </a> ","plainDigest":"$天星医疗(01609)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1777882826001,"gmtModify":1777883483252,"symbols":["01609"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/b4706504d1cb6affaadeef288f97b3d3","width":"882","height":"1620"}],"repostCount":0,"viewCount":951,"likeCount":3,"liked":false,"collected":false,"commentCount":1,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/560541864522912","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":17,"displayRows":4,"foldSize":0,"authorId":"4182048476464190"}]},{"cardType":"TWEET","cardId":"TWEET.560804059971712","cardData":[{"tweetId":"560804059971712","author":{"authorId":"4138284538774192","idStr":"4138284538774192","name":"Tigerwood1234","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":12,"crmLevelSwitch":0,"wearingBadges":[],"fanSize":1,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://ttm.financial/S/01609\">$天星医疗(01609)$</a> 先食肉","plainDigest":"$天星医疗(01609)$ 先食肉","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1777946860045,"gmtModify":1777946864739,"symbols":["01609"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://community-static.tradeup.com/news/2e4751a783ef3c7dae70e35839a1b4ab","width":"1179","height":"2130"}],"repostCount":0,"viewCount":357,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/560804059971712","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":23,"displayRows":4,"foldSize":0,"authorId":"4138284538774192"}]},{"cardType":"TWEET","cardId":"TWEET.560626851189656","cardData":[{"tweetId":"560626851189656","author":{"authorId":"3498690247998564","idStr":"3498690247998564","name":"二狗叨叨","avatar":"https://static.tigerbbs.com/55e1bdc35fbca55dc650568445c5703e","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":1,"crmLevelSwitch":1,"wearingBadges":[],"fanSize":1972,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"【港股打新】乐动机器人 申购策略","digest":"五一小长假继续，大A股不开盘，港股打了鸡血，恒指和恒科都暴涨，尤其是下午 <a href=\"https://laohu8.com/S/01609\">$天星医疗(01609)$</a> 暗盘，暴涨200+%，一手至少赚1w，真的是大超预期。。。 只可惜，二狗哥没中，没吃到肉。。。。 一、基本信息 <a href=\"https://laohu8.com/S/01236\">$乐动机器人(01236)$</a> ，成立于 2017 年，是全球领先的全栈式智能机器人视觉感知企业，聚焦机器人 “传感器+算法+云平台” 核心技术，成为“智能机器人移动感知第一股”。。。 公司构建To B视觉感知解决方案与To C智能割草机器人双轮驱动格局，自研DTOF激光雷达2024年出货量全球第一，技术赋能超600万台智能机器人，服务全球 300余家头部客户，业务覆盖50余个国家和地区。。。 二、招股信息 公司名称及代码：乐动机器人（01236.HK） 招股价：24.00-30.00KD 入场费：6060.51HKD（1手200股） 招股日期：04月30至05月06日，本周三截止 公布中签：05月07日 上市：05月11日 发售股份：3333.34w股，占总股本10% 分配机制：机制B 市值：80-100亿HKD 绿鞋：有。。。 基石：1名基石共认购占比30.78%。。。 保荐人：海通、国泰 三、基本面情况 公司在2022年、2023年和2024年，实现营收分别约为2.77亿元、4.67亿元、7.48亿，复合年增长率64%，期间公司净利润分别为-0.68亿元、-0.56亿元、-0.63亿元，复合年增长率21.3%。。。 四、申购策略 1、公司基本面一般情况，发展很快，不过还未盈利。。。。 2、概念不错，能炒一波。。。 3、公司按照机制B发行，甲乙组共计16666手，货不多，今天下午天星的资金也回来了，估","plainDigest":"五一小长假继续，大A股不开盘，港股打了鸡血，恒指和恒科都暴涨，尤其是下午 $天星医疗(01609)$ 暗盘，暴涨200+%，一手至少赚1w，真的是大超预期。。。 只可惜，二狗哥没中，没吃到肉。。。。 一、基本信息 $乐动机器人(01236)$ ，成立于 2017 年，是全球领先的全栈式智能机器人视觉感知企业，聚焦机器人 “传感器+算法+云平台” 核心技术，成为“智能机器人移动感知第一股”。。。 公司构建To B视觉感知解决方案与To C智能割草机器人双轮驱动格局，自研DTOF激光雷达2024年出货量全球第一，技术赋能超600万台智能机器人，服务全球 300余家头部客户，业务覆盖50余个国家和地区。。。 二、招股信息 公司名称及代码：乐动机器人（01236.HK） 招股价：24.00-30.00KD 入场费：6060.51HKD（1手200股） 招股日期：04月30至05月06日，本周三截止 公布中签：05月07日 上市：05月11日 发售股份：3333.34w股，占总股本10% 分配机制：机制B 市值：80-100亿HKD 绿鞋：有。。。 基石：1名基石共认购占比30.78%。。。 保荐人：海通、国泰 三、基本面情况 公司在2022年、2023年和2024年，实现营收分别约为2.77亿元、4.67亿元、7.48亿，复合年增长率64%，期间公司净利润分别为-0.68亿元、-0.56亿元、-0.63亿元，复合年增长率21.3%。。。 四、申购策略 1、公司基本面一般情况，发展很快，不过还未盈利。。。。 2、概念不错，能炒一波。。。 3、公司按照机制B发行，甲乙组共计16666手，货不多，今天下午天星的资金也回来了，估","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1777903489194,"gmtModify":1777971271744,"symbols":["01236","01609","01879"],"themeIds":["e4363384c4254650b897c0f13fe1588f"],"popularizeThemeFlag":false,"imageCount":3,"images":[{"url":"https://static.tigerbbs.com/9b6cb9ee7603cd984165dcdb93dd241d","width":"1080","height":"592"},{"url":"https://static.tigerbbs.com/4a0bd234cee082ad33b417ddbdc287cb","width":"1280","height":"2781"},{"url":"https://static.tigerbbs.com/45bc1157bf6992f25a8af804a91b2ebe","width":"1080","height":"1070"}],"repostCount":0,"viewCount":12771,"likeCount":4,"liked":false,"collected":false,"commentCount":3,"hotComments":[{"id":"560892726817416","author":{"authorId":"3575862927081112","idStr":"3575862927081112","name":"采桑散人","avatar":"https://static.tigerbbs.com/bb1f6513a46c196801e977946b5c3200","userType":1,"introduction":"","crmLevel":6,"crmLevelSwitch":0,"fanSize":25,"starInvestorFlag":false},"content":"二狗哥，你用的什么APP？@二狗叨叨 ","plainContent":"二狗哥，你用的什么APP？@二狗叨叨 ","likeCount":0,"commentType":"valid","coins":0},{"id":"560645975658560","author":{"authorId":"9000000000000692","idStr":"9000000000000692","name":"BartonBecky","avatar":"https://static.tigerbbs.com/fde9003fb484c9e374d5eaed0de72bd3","userType":8,"introduction":"运营账号","crmLevel":1,"crmLevelSwitch":0,"fanSize":25,"starInvestorFlag":false},"content":"没想到天星这么猛，吃瓜没赶上啊","plainContent":"没想到天星这么猛，吃瓜没赶上啊","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/560626851189656","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1760,"displayRows":4,"foldSize":0,"authorId":"3498690247998564"}]},{"cardType":"TWEET","cardId":"TWEET.560645730718048","cardData":[{"tweetId":"560645730718048","author":{"authorId":"4145690077805192","idStr":"4145690077805192","name":"Frankie Kan","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":12,"crmLevelSwitch":0,"wearingBadges":[],"fanSize":1,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://ttm.financial/S/01609\">$天星医疗(01609)$ </a> 我猜明天开市升少下午跌","plainDigest":"$天星医疗(01609)$ 我猜明天开市升少下午跌","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1777908216936,"gmtModify":1777908221711,"symbols":["01609"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":341,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/560645730718048","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":39,"displayRows":4,"foldSize":0,"authorId":"4145690077805192"}]}],"size":10},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"21085247","market":"hk","labels":[],"media":"港交所","original_id":"N.HKJ1CV55ycuw","pdf_url":"https://static.tigerbbs.com/3c5610831ec349a785e4d22689675a4c","pub_time":1776982380000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"全球发售","symbol":"01609","title":"全球发售","titleType":"股份发售","type":"hkIPO","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0424/2026042400054_c.pdf","us_notice_code":"上市文件 - [发售以供认购]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"上市文件","type_name_en":"Listing Document","titleTypeEn":"Shares Subscription","event_type":"important_notice","event_name":"股份发售","pubTime":"2026-04-24 06:13","pubTimestamp":1776982380,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17354408","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHqfq6LQ9fJ","pdf_url":"https://static.tigerbbs.com/2f77e270a5ee4920b12989b95e43f8ae","pub_time":1702630860000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"中期报告2023","symbol":"01609","title":"中期报告2023","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/1215/2023121500439_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2023-12-15 17:01","pubTimestamp":1702630860,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17253965","market":"hk","labels":[],"media":"港交所","original_id":"N.HK6PVhZ3UiFX","pdf_url":"https://static.tigerbbs.com/48568abde11f4ad1bd10457b72293450","pub_time":1700740800000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至二零二三年九月三十日止六个月的中期业绩公告","symbol":"01609","title":"截至二零二三年九月三十日止六个月的中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/1123/2023112301118_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2023-11-23 20:00","pubTimestamp":1700740800,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17244741","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7WBVfe1ib1","pdf_url":"https://static.tigerbbs.com/9550299c35fd455983d975f718d3e03b","pub_time":1700574300000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1)有关收购广州市祥景陵园有限公司59%股权之非常重大收购事项及关连交易；(2)涉及新上市申请之反收购；及(3)有关贷款转让之须予披露及关连交易","symbol":"01609","title":"(1)有关收购广州市祥景陵园有限公司59%股权之非常重大收购事项及关连交易；(2)涉及新上市申请之反收购；及(3)有关贷款转让之须予披露及关连交易","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/1121/2023112100996_c.pdf","us_notice_code":"公告及通告 - [非常重大的收购事项 / 反收购 / 须予披露的交易 / 关连交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2023-11-21 21:45","pubTimestamp":1700574300,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17021576","market":"hk","labels":[],"media":"港交所","original_id":"N.HK69vbZtGu9g","pdf_url":"https://static.tigerbbs.com/714bcda7195c431aa693cbca249a15bf","pub_time":1695991140000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1)红日资本有限公司代表创建集团（控股）有限公司提出回购最多120,000,000股股份作注销并交换经调整国耀股份的有条件股份回购结束；(2)回购要约结束；及(3)回购要约结算","symbol":"01609","title":"(1)红日资本有限公司代表创建集团（控股）有限公司提出回购最多120,000,000股股份作注销并交换经调整国耀股份的有条件股份回购结束；(2)回购要约结束；及(3)回购要约结算","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0929/2023092901231_c.pdf","us_notice_code":"公告及通告 - [根据《公司股份回购守则》发出的公告 / 《收购守则》所指的受要约公司刊发的公告 / 《收购守则》所指的要...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2023-09-29 20:39","pubTimestamp":1695991140,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16962449","market":"hk","labels":[],"media":"港交所","original_id":"N.HKxts9SiNcu4","pdf_url":"https://static.tigerbbs.com/8f7e88fac51a4d78b8cf1f51fb273757","pub_time":1694776320000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"(1)于二零二三年九月十五日举行的股东特别大会投票表决结果(2)回购要约在所有方面成为无条件及(3)回购要约仍可供接纳","symbol":"01609","title":"(1)于二零二三年九月十五日举行的股东特别大会投票表决结果(2)回购要约在所有方面成为无条件及(3)回购要约仍可供接纳","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0915/2023091501034_c.pdf","us_notice_code":"公告及通告 - [股东特别大会的结果 / 《收购守则》所指的受要约公司刊发的公告 / 《收购守则》所指的要约公司刊发的公告...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2023-09-15 19:12","pubTimestamp":1694776320,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16848353","market":"hk","labels":[],"media":"港交所","original_id":"N.HK2GqTTngsgH","pdf_url":"https://static.tigerbbs.com/173a16d726db4968be689f8010397ba3","pub_time":1692878340000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件","symbol":"01609","title":"延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0824/2023082401173_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的受要约公司刊发的公告 / 《收购守则》所指的要约公司刊发的公告 / 主要交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2023-08-24 19:59","pubTimestamp":1692878340,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16841292","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7CRTXGM3aX","pdf_url":"https://static.tigerbbs.com/bcd291723e924a60abef3c454afe50f7","pub_time":1692829740000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"创建集团（控股）有限公司已发行股本中每股面值0.01港元普通股之接纳及转让表格","symbol":"01609","title":"创建集团（控股）有限公司已发行股本中每股面值0.01港元普通股之接纳及转让表格","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0824/2023082400044_c.pdf","us_notice_code":"通函 - [《收购守则》所指的要约公司发出的文件]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2023-08-24 06:29","pubTimestamp":1692829740,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16841286","market":"hk","labels":[],"media":"港交所","original_id":"N.HKCEn6Qaovzw","pdf_url":"https://static.tigerbbs.com/fbdc31e7eca74578bed1bedfa17b239b","pub_time":1692829140000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"要约文件(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易及股东特别大会通告","symbol":"01609","title":"要约文件(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易及股东特别大会通告","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0824/2023082400022_c.pdf","us_notice_code":"通函 - [《收购守则》所指的受要约公司发出的文件 / 《收购守则》所指的要约公司发出的文件 / 主要交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2023-08-24 06:19","pubTimestamp":1692829140,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16810597","market":"hk","labels":[],"media":"港交所","original_id":"N.HKAkgGTdDdRy","pdf_url":"https://static.tigerbbs.com/b2b6c9ca9a28411f89b6f4a6fe6e5927","pub_time":1692364860000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份；及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件","symbol":"01609","title":"进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份；及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0818/2023081801527_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的受要约公司刊发的公告 / 《收购守则》所指的要约公司刊发的公告 / 延迟发送通函或其他文件]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2023-08-18 21:21","pubTimestamp":1692364860,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16697418","market":"hk","labels":[],"media":"港交所","original_id":"N.HKBkMs2hSqbL","pdf_url":"https://static.tigerbbs.com/f792e8473d334420b6fdd314b1975303","pub_time":1689941760000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件","symbol":"01609","title":"进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0721/2023072101017_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的受要约公司刊发的公告 / 《收购守则》所指的要约公司刊发的公告 / 延迟发送通函或其他文件]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2023-07-21 20:16","pubTimestamp":1689941760,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16670069","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHuZ4CEXYrc","pdf_url":"https://static.tigerbbs.com/22a7d28689b9488a80b2a88d76e179fe","pub_time":1689168000000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"2023 年报","symbol":"01609","title":"2023 年报","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0712/2023071200797_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报 / 环境、社会及管治资料/报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2023-07-12 21:20","pubTimestamp":1689168000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16670032","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3wLYsuHsqb","pdf_url":"https://static.tigerbbs.com/b9c78bd9841047f5b95758d416569b06","pub_time":1689166740000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"建议更新发行新股份及回购股份的一般授权、扩大发行授权、重选退任董事、续聘独立核数师、建议修订组织章程大纲及细则及采纳经修订及重述组织章程大纲及细则及股东周年大会通告","symbol":"01609","title":"建议更新发行新股份及回购股份的一般授权、扩大发行授权、重选退任董事、续聘独立核数师、建议修订组织章程大纲及细则及采纳经修订及重述组织章程大纲及细则及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0712/2023071200775_c.pdf","us_notice_code":"通函 - [在股东批准的情况下重选或委任董事 / 回购股份的说明函件 / 一般性授权]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2023-07-12 20:59","pubTimestamp":1689166740,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16611817","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGMbonjz8wg","pdf_url":"https://static.tigerbbs.com/1cab26397bce4849b60b774744ba8d90","pub_time":1687790640000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件","symbol":"01609","title":"进一步延迟寄发有关(1)红日资本有限公司代表创建集团（控股）有限公司提出有条件股份回购回购最多120,000,000股股份作注销并交换经调整国耀股份及(2)有关出售国耀控股有限公司全部已发行股本之潜在主要交易之要约文件","titleType":"收购","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0626/2023062601157_c.pdf","us_notice_code":"公告及通告 - [《收购守则》所指的受要约公司刊发的公告 / 《收购守则》所指的要约公司刊发的公告 / 延迟发送通函或其他文件]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Acquisition","event_type":"important_notice","event_name":"收购","pubTime":"2023-06-26 22:44","pubTimestamp":1687790640,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16567053","market":"hk","labels":[],"media":"港交所","original_id":"N.HKto1a3hygrk","pdf_url":"https://static.tigerbbs.com/cfc71614de714ff28ed084bb6e80a091","pub_time":1686581580000,"showTitleType":false,"size":0,"source":"hk_ex_news","summary":"截至二零二三年三月三十一日止年度之全年业绩公告","symbol":"01609","title":"截至二零二三年三月三十一日止年度之全年业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0612/2023061201157_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2023-06-12 22:53","pubTimestamp":1686581580,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.starsportmed.com/","stockEarnings":[{"period":"1week","weight":1.0406},{"period":"ytd","weight":1.0406}],"compareEarnings":[{"period":"1week","weight":0.0239},{"period":"1month","weight":0.0193},{"period":"3month","weight":-0.0063},{"period":"6month","weight":0.0058},{"period":"1year","weight":0.1588},{"period":"ytd","weight":0.0298}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京天星医疗股份有限公司(简称“天星医疗”)作为国产运动医学的领导者,致力于提供运动医学的整体临床解决方案,公司坐落于北京经济技术开发区,注册资本4000多万,现有员工200余人。应用于肩关节、膝关节、足/踝关节、髋关节、肘关节、手/腕关节的运动医学设备、植入物和手术器械共计300多个品规通过NMPA的批准,临床应用于国内31个省市、自治区的数千家医院。主要从事运动医学植入物、有源设备及耗材,以及手术工具的研发、生产与销售。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.121197},{"month":2,"riseRate":0.5,"avgChangeRate":0.06192},{"month":3,"riseRate":0.428571,"avgChangeRate":0.034993},{"month":4,"riseRate":0.5,"avgChangeRate":-0.011524},{"month":5,"riseRate":0.5,"avgChangeRate":0.066004},{"month":6,"riseRate":0.2,"avgChangeRate":-0.212662},{"month":7,"riseRate":0.4,"avgChangeRate":0.059988},{"month":8,"riseRate":0.4,"avgChangeRate":0.05496},{"month":9,"riseRate":0.4,"avgChangeRate":-0.011761},{"month":10,"riseRate":0.4,"avgChangeRate":-0.000213},{"month":11,"riseRate":0.333333,"avgChangeRate":0.179457},{"month":12,"riseRate":0.5,"avgChangeRate":0.080552}],"exchange":"SEHK","name":"天星医疗","nameEN":"STAR SPORTS MED"},"aProfile":null}}}